Ha HR - Search Results

1

[Short-term dobutamine therapy in severe cardiac insufficiency].

Weiss P, Schmidlin O, Ha HR, Ritz R, Follath F. Weiss P, et al. Among authors: ha hr. Schweiz Med Wochenschr. 1990 Feb 10;120(6):190-3. Schweiz Med Wochenschr. 1990. PMID: 2305231 German.

2

Concentration-effect relations of 5-hydroxypropafenone in normal subjects.

Haefeli WE, Vozeh S, Ha HR, Taeschner W, Follath F. Haefeli WE, et al. Among authors: ha hr. Am J Cardiol. 1991 May 1;67(11):1022-6. doi: 10.1016/0002-9149(91)90177-m. Am J Cardiol. 1991. PMID: 2018005 Clinical Trial.

3

Population pharmacokinetics of quinidine.

Fattinger K, Vozeh S, Ha HR, Borner M, Follath F. Fattinger K, et al. Among authors: ha hr. Br J Clin Pharmacol. 1991 Mar;31(3):279-86. doi: 10.1111/j.1365-2125.1991.tb05531.x. Br J Clin Pharmacol. 1991. PMID: 2054269 Free PMC article.

4

Nonlinear kinetics of propafenone metabolites in healthy man.

Vozeh S, Haefeli W, Ha HR, Vlcek J, Follath F. Vozeh S, et al. Among authors: ha hr. Eur J Clin Pharmacol. 1990;38(5):509-13. doi: 10.1007/BF02336693. Eur J Clin Pharmacol. 1990. PMID: 2379537

5

Comparison of the pharmacodynamic effects of intravenous and oral propafenone.

Haefeli EW, Vozeh S, Ha HR, Follath F. Haefeli EW, et al. Among authors: ha hr. Clin Pharmacol Ther. 1990 Sep;48(3):245-54. doi: 10.1038/clpt.1990.146. Clin Pharmacol Ther. 1990. PMID: 2401123 Clinical Trial.

6

Hemodynamic effects and concentration-effect relationship of a graded infusion of piroximone in patients with severe heart failure.

Baumann PC, Meyer BJ, Maggiorini M, Ha HR, Gallino A, Follath F. Baumann PC, et al. Among authors: ha hr. J Cardiovasc Pharmacol. 1993 Mar;21(3):489-95. doi: 10.1097/00005344-199303000-00021. J Cardiovasc Pharmacol. 1993. PMID: 7681513

7

The relative potency of major metabolites and enantiomers of propafenone in an experimental reperfusion arrhythmia model.

Oti-Amoako K, Vozeh S, Ha HR, Follath F. Oti-Amoako K, et al. Among authors: ha hr. J Cardiovasc Pharmacol. 1990 Jan;15(1):75-81. doi: 10.1097/00005344-199001000-00012. J Cardiovasc Pharmacol. 1990. PMID: 1688986

8

Once a day verapamil in essential hypertension.

Müller FB, Ha HR, Hotz H, Schmidlin O, Follath F, Bühler FR. Müller FB, et al. Among authors: ha hr. Br J Clin Pharmacol. 1986;21 Suppl 2(Suppl 2):143S-147S. doi: 10.1111/j.1365-2125.1986.tb02863.x. Br J Clin Pharmacol. 1986. PMID: 3530298 Free PMC article.

9

Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure.

Candinas R, Frielingsdorf J, Ha HR, Carrel T, Turina M, Follath F. Candinas R, et al. Among authors: ha hr. Eur J Clin Pharmacol. 1998 Jan;53(5):331-6. doi: 10.1007/s002280050388. Eur J Clin Pharmacol. 1998. PMID: 9516032

10

Coronary ligation-reperfusion arrhythmia models in anesthetized rats and isolated perfused rat hearts concentration-effect relationships of lidocaine.

Uematsu T, Vozeh S, Ha HR, Hof RP, Follath F. Uematsu T, et al. Among authors: ha hr. J Pharmacol Methods. 1986 Aug;16(1):53-61. doi: 10.1016/0160-5402(86)90028-8. J Pharmacol Methods. 1986. PMID: 3747546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters